Evidence map›Paper›PMID 22196222›Full record

ReviewCritical reviews in biomedical engineering2011

Encapsulated cell grafts to treat cellular deficiencies and dysfunction.

N V Krishnamurthy, Barjor Gimi

Abstract readReview
In one paragraph

Review in Critical reviews in biomedical engineering, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Noninvasive Tracking of Alginate-Microencapsulated Cells.Methods in molecular biology (Clifton, N.J.) · 2017
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Islet and stem cell encapsulation for clinical transplantation.The review of diabetic studies : RDS · 2014
    Review
  16. Article
  17. In vitro and in vivo evaluation of SU-8 biocompatibility.Materials science & engineering. C, Materials for biological applications · 2013
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

N V KrishnamurthyDepartment of Radiology, Dartmouth Medical School, Hanover, NH, USA.
Barjor Gimi

Funding

Imaging islets in implantable microcapsulesR01EB007456 · NIBIB · UT SOUTHWESTERN MEDICAL CENTER · PI GIMI, BARJOR · 2006 to 2008
$1.2M
NIBIB NIH HHS EB007456NIBIB NIH HHS R01 EB007456
6 · The paper itself

Abstract

Cell transplantation provides a therapeutic alternative to whole organ transplantation in the management of diseases arising from the absence or failure of specialized cells. Though allogenic transplantation is favorable in terms of graft acceptance, xenotransplantation can provide a potentially unlimited source of cells and can overcome shortage of human donors. Effective immunoisolation of the xenografts is critical for their long term survival and function. Encapsulation of cells in polymeric matrices, organic or inorganic, provides a physical selectively permeable barrier between the host and the graft, thereby immunoisolating the graft. Microencapsulation of cells in alginate hydrogels has been pervasive, but this approach does not provide precise control over porosity, whereas micro- and nano-fabrication technologies can provide precise and reproducible control over porosity. We highlight both encapsulation approaches in this review, with their relative advantages and challenges. We also highlight the therapeutic potential of encapsulated cells for treating a variety of diseases, detailing the xenotransplantation of pancreatic islets in diabetes therapy as well as the grafting of engineered cells that facilitate localized enzyme-prodrug therapy of pancreatic cancer.

Indexed as

Graft SurvivalAlginatesAnimalsCricetinaeDiabetes Mellitus, Type 1HumansIslets of LangerhansIslets of Langerhans TransplantationMethylmethacrylatesMiceNanomedicineNanostructuresNeoplasmsPolyhydroxyethyl MethacrylatePolylysineStem CellsAlginatesHTR compositeMethylmethacrylatesPolyhydroxyethyl MethacrylatePolylysine

Identifiers

PMID22196222
PMCPMC3246397

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.